Platinum Priority – Review – Kidney CancerEditorial by Mehrad Adibi, Jose A. Karam and Christopher G. Wood on pp. 531–532 of this issueInternational Variations and Trends in Renal Cell Carcinoma Incidence and Mortality
Introduction
In 2012 there were an estimated 338 000 new cases of kidney cancer worldwide [1]. Renal cell carcinoma (RCC) comprises more than 90% of such malignancies, with clear cell (70%), papillary (10–15%), and chromophobe (5%) carcinoma the main histologic types [2]. Kidney cancer is currently the ninth most common cancer in men (214 000 cases) and the 14th most common in women (124 000 cases) worldwide. There were an estimated 143 000 deaths from kidney cancer in 2012 (91 000 in men, 52 000 in women), with the disease ranking as the 16th most common cause of death from cancer worldwide.
Rates vary 15-fold worldwide. The highest incidence rates are found in the Czech Republic, and rates are elevated in Northern and Eastern Europe, North America, and Australia. Relatively low rates are estimated in much of Africa and South-East Asia [1]. Increasing incidence trends have been reported worldwide, with some evidence of stabilisation in most developed countries [3].
Established lifestyle risk factors for RCC include smoking and obesity [4], [5]: smoking increases the risk of RCC by 50% in male and 20% in female smokers [6], and 5-kg/m2 increments in body mass index (BMI) increase the risk of RCC by 24% in men and 34% in women [5]. In terms of occupational exposure, only trichloroethylene has been evaluated as a human carcinogen [7]. It has been reported that hypertension is an independent risk factor for RCC [8], and patients on maintenance dialysis also appear to have an increased risk of kidney cancer [9]. Fruit and vegetable consumption (in particular cruciferous vegetables) has been associated with a reduction in the risk of RCC [10], [11]. Approximately 2–3% of RCC cases are familial, with a twofold higher risk among first-degree relatives of RCC patients. RCC can develop within certain syndromes, of which von Hippel Lindau is the most common [2]. A recent survey by the Cancer Genome Atlas Research Network identified 19 mutated genes of statistical significance including VHL, PBRM1, SETD2, KDM5C, PTEN, BAP1, MTOR, and TP53 [12]. Gene-environment interactions have also been reported [13], [14].
RCC incidence rates tend to be elevated at older ages and in more developed countries, where 70% of new cases occur (34% in Europe and 19% in North America) [1], and more than half of cases may be discovered incidentally [15], [16], [17]. The profound increases in incidence are largely attributable to the increase in localised tumours [18], [19]. Declining mortality trends have been reported for some highly developed European countries since the 1990s [20], [21].
The aim of this study was to comprehensively describe and compare variations and trends in RCC incidence and mortality worldwide, and interpret these epidemiological observations in the context of disease control by reviewing relevant changes in diagnostic practices, risk factors, and treatment regimens.
Section snippets
Evidence acquisition
RCC has been defined as malignant neoplasms of the kidney, except the renal pelvis (ICD-10 C64). Geographic and temporal patterns of observed RCC incidence were examined using data series from regional or national population-based cancer registries extracted from Cancer Incidence in Five Continents (CI5) Volumes I–X [22]. The requirement for inclusion was at least 15 consecutive years of data and compilation in the last volume of the CI5 series, a criterion indicative of the data quality of
Geographic variation of incidence and mortality rates
Among men, RCC incidence rates in 2012 (cases per 100 000 population) vary from approximately 1 in African countries to >15 in the Baltic countries, Belarus, Czech Republic, and Slovakia, and in US blacks. The highest incidence rates worldwide are observed in the Czech Republic (22.0/100 000 in men and 9.9/100 000 in women), with intermediate rates among US whites and in Canada, Australia, and New Zealand. The lowest rates are seen in most African and Asian populations, with the exception of
Discussion
We observed great disparities in RCC incidence rates worldwide, ranging from 22/100 000 in Czech men to <1/100 000 in African countries. Furthermore, over the most recent 10-yr period, incidence increased in 33 out of 43 populations under study in men and in 21 populations in women, most prominently in Latin American populations, where annual increases of over 3% were observed in both sexes. By contrast, mortality trends have been more favourable, with rather few concomitant increases in
Conclusions
The study of RCC confirms a need for continued surveillance and in particular for analysis of patterns and trends in incidence, mortality, and survival in parallel given the synergy between these indicators. Disentangling the effects of smoking and obesity remains complex, and the documented risk factors for RCC are exclusively those reported for developed settings. Obesity levels, as measured in terms of BMI, have been increasing worldwide, and smoking is on the rise in countries in
References (43)
- et al.
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
Lancet
(2008) - et al.
Carcinogenicity of trichloroethylene, tetrachloroethylene, some other chlorinated solvents, and their metabolites
Lancet Oncol
(2012) - et al.
The evolving presentation of renal carcinoma in the United States: trends from the Surveillance, Epidemiology, and End Results program
J Urol
(2006) - et al.
Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis
Eur Urol
(2011) - et al.
Trends in mortality from urologic cancers in Europe, 1970–2008
Eur Urol
(2011) - et al.
International trends in lung cancer incidence by histological subtype: adenocarcinoma stabilizing in men but still increasing in women
Lung Cancer
(2014) - et al.
International variations and trends in testicular cancer incidence and mortality
Eur Urol
(2014) - et al.
International variation in prostate cancer incidence and mortality rates
Eur Urol
(2012) - et al.
Management of kidney cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2012
Lancet Oncol
(2012) - et al.
Contemporary management of small renal masses
Eur Urol
(2011)
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Ann Oncol
Access to targeted therapies in renal cell cancer
Semin Oncol
Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study
Lancet Oncol
The association of the human development index with global kidney cancer incidence and mortality
J Urol
GLOBOCAN 2012, cancer incidence and mortality worldwide: IARC CancerBase No. 11
Pathology and genetics of tumours of the urinary system and male genital organs. World Health Organisation classification of tumours
Epidemiology and risk factors for kidney cancer
Nat Rev Urol
Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies
Int J Cancer
Blood pressure and risk of renal cell carcinoma in the European prospective investigation into cancer and nutrition
Am J Epidemiol
Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand
J Am Soc Nephrol
Cited by (723)
Safety and Technical Feasibility of Percutaneous Renal Cryoablation of Central Tumors without Pyeloperfusion
2024, Journal of Vascular and Interventional RadiologyMultimodal deep learning for personalized renal cell carcinoma prognosis: Integrating CT imaging and clinical data
2024, Computer Methods and Programs in BiomedicineCirculating tumor cells as a predictor and prognostic tool for metastatic clear cell renal carcinoma: An immunocytochemistry and genomic analysis
2024, Pathology Research and Practice